P1503: REAL WORLD DATA ON EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS.

Detalles Bibliográficos
Autores principales: Elenga, N., Etienne-Julan, M., Loko, G., AlOkka, R., Adel, A., Yassin, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431337/
http://dx.doi.org/10.1097/01.HS9.0000848868.53553.7f
_version_ 1784780027079950336
author Elenga, N.
Etienne-Julan, M.
Loko, G.
AlOkka, R.
Adel, A.
Yassin, M.
author_facet Elenga, N.
Etienne-Julan, M.
Loko, G.
AlOkka, R.
Adel, A.
Yassin, M.
author_sort Elenga, N.
collection PubMed
description
format Online
Article
Text
id pubmed-9431337
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94313372022-08-31 P1503: REAL WORLD DATA ON EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS. Elenga, N. Etienne-Julan, M. Loko, G. AlOkka, R. Adel, A. Yassin, M. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431337/ http://dx.doi.org/10.1097/01.HS9.0000848868.53553.7f Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Elenga, N.
Etienne-Julan, M.
Loko, G.
AlOkka, R.
Adel, A.
Yassin, M.
P1503: REAL WORLD DATA ON EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS.
title P1503: REAL WORLD DATA ON EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS.
title_full P1503: REAL WORLD DATA ON EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS.
title_fullStr P1503: REAL WORLD DATA ON EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS.
title_full_unstemmed P1503: REAL WORLD DATA ON EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS.
title_short P1503: REAL WORLD DATA ON EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS.
title_sort p1503: real world data on efficacy of pharmaceutical-grade l-glutamine in preventing sickle cell disease-related acute complications and hemolysis in pediatric and adult patients.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431337/
http://dx.doi.org/10.1097/01.HS9.0000848868.53553.7f
work_keys_str_mv AT elengan p1503realworlddataonefficacyofpharmaceuticalgradelglutamineinpreventingsicklecelldiseaserelatedacutecomplicationsandhemolysisinpediatricandadultpatients
AT etiennejulanm p1503realworlddataonefficacyofpharmaceuticalgradelglutamineinpreventingsicklecelldiseaserelatedacutecomplicationsandhemolysisinpediatricandadultpatients
AT lokog p1503realworlddataonefficacyofpharmaceuticalgradelglutamineinpreventingsicklecelldiseaserelatedacutecomplicationsandhemolysisinpediatricandadultpatients
AT alokkar p1503realworlddataonefficacyofpharmaceuticalgradelglutamineinpreventingsicklecelldiseaserelatedacutecomplicationsandhemolysisinpediatricandadultpatients
AT adela p1503realworlddataonefficacyofpharmaceuticalgradelglutamineinpreventingsicklecelldiseaserelatedacutecomplicationsandhemolysisinpediatricandadultpatients
AT yassinm p1503realworlddataonefficacyofpharmaceuticalgradelglutamineinpreventingsicklecelldiseaserelatedacutecomplicationsandhemolysisinpediatricandadultpatients

Ejemplares similares